Would a leaflet that explains the benefits of a third party developed patient app being disseminated to patients via a branded PSP require PAAB review? The leaflet would not mention the specific PSP or brand. It would only discuss the app. The app itself was reviewed as part of a branded patient brochure under 'addition lifestyle resources' and was deemed acceptable by PAAB.
D
Danielle
@Danielle
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Posts
-
Third-Party Unbranded Patient App - Communications -
133 - Can a non-gated medical journal web site, whose online advertising is restricted to reminder ads and non-pharma ads, offer unrestricted access to a complete digital version of back issues of the journal (Rx advertising would appear as it does in print)?@jennifer-carroll Hi Jennifer, does a reminder ad with indication statement running in a specialty pub require anything more if the drug has a black box warning? Only brand colours and logo would be used, no creative/visuals.
-
Patient Lifestyle AppsHello,
I'd like to understand how lifestyle apps can be leveraged in branded patient materials when cited as available resources and or lifestyle support apps produced by third parties, including authoritative sources and independent 3rd parties. ie. the apps are not brand specific but would be cited as available resources for patients within a branded patient tool.
Is there any difference if the apps focus on: (1) lifestyle and nutrition (2) lifestyle, nutrition and disease informationLastly, does context change if access to the app is only provided via a PSP program but the app remains developed by a 3rd party with the manufacturer having no ownership over the app or the app content.
-
Bill 92Hello,
We would like to understand any rule/restrictions around communicating that a particular patient assistance card being distributed in Quebec is not affected by the new Bill 92. For example, would language such as '...not impacted by Bill 92 and can still be used at Pharmacies across Quebec.' be approvable?Danielle
-
Patient Satisfaction ClaimsWe are looking to better understand if patient satisfaction claims can be used in the context of HCP communications. If so, could you please specify the parameters we would need to consider? The brand does not have a PSP. Could a patient be surveyed by a third party to determine non-subjective satisfaction measures? Is there an ability to also survey around perception of efficacy, tolerability, ease of use, and preference?